Digital Exclusive: An interview with David Eichenbaum, MD, on his ASRS 2024 presentation

David Eichenbaum, MD, spoke with Modern Retina to provide and overview on his presentation at ASRS 2024 and the current state of geographic atrophy treatment.

For years, geographic atrophy (GA) was a condition that had no approved treatments in the US or abroad. In 2023, there was a notable change: Not only 1, but 2 treatments for GA received FDA approval, opening the doors for retina specialists to begin offering treatment to patients with GA.